About time you finally realized that this is a dead dog. No money and bad management usually equal liquidation in the spec space. Not long now. RIP CRS. And you put me on ignore for mentioning the obvious re finance.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
About time you finally realized that this is a dead dog. No...
Featured News
Add CRS (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.468M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 70649 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 3715 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70649 | 0.017 |
2 | 984507 | 0.016 |
2 | 233334 | 0.015 |
2 | 1142857 | 0.014 |
1 | 76999 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 3715 | 1 |
0.026 | 35000 | 1 |
0.035 | 100000 | 1 |
0.040 | 140000 | 3 |
0.048 | 177778 | 1 |
Last trade - 16.12pm 06/05/2024 (20 minute delay) ? |
Featured News
CRS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online